Dr Hatchett served as Chief Medical Officer and Deputy Director of BARDA from January 2011 to March 2016 and as acting Director of BARDA from March to November 2016. Previously, he served as Director for Medical Preparedness Policy on the White House National Security Staff where he worked on a wide array of issues related to medical countermeasures development, the 2009-H1N1 pandemic, and pandemic preparedness more broadly. In 2005 – 2006, he served as Director for Biodefense Policy on the White House Homeland Security Council and was a principal author of the National Strategy for Pandemic Influenza Implementation Plan. In this capacity, he helped set policy and devise strategies to mitigate the consequences of a pandemic and promote pandemic preparedness. From 2005 – 2011, he served as Associate Director for Radiation Countermeasures Research and Emergency Preparedness at the National Institute of Allergy and Infectious Diseases.

Dr Hatchett completed his undergraduate and medical educations at Vanderbilt University, an internship and residency in Internal Medicine at New York Hospital – Cornell Medical Center, and a fellowship in Medical Oncology at the Duke University Medical Center.

Dr Hatchett is intending to begin his work as the CEPI CEO in April 2017.